{
    "medicine_id": "cb15665370d6d1976933fdf06f5b09827d6c00cf",
    "platform_id": "DB05447",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v AVI 4557",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in adverse effects chemotherapy and adverse effects drug",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "selectively inhibits the metabolic enzyme cytochrome P450 3A4 CYP a liver enzyme responsible for the metabolism or breakdown of approximately half of currently marketed drugs Studies indicate that AVI 4557 can successfully reduce the rate of metabolism when co administered with certain therapeutic drugs allowing greater and longer availability of the drug in the patient s system without an increase in toxicity",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}